This inventor holds 0 USPTO granted patents, plus 5 CIPO patents.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Title: Jean Gudas - Innovator in Antibody Drug Conjugates
Introduction
Jean Gudas is an inventor based in the United States, known for his work in the field of antibody drug conjugates (ADCs). His innovative approach focuses on developing therapeutic compositions that target specific proteins associated with cancer. Although he currently holds no patents, his research has significant implications for cancer treatment.
Latest Patents
Jean Gudas has developed a notable concept involving antibody drug conjugates that bind to the 191P4D12 protein. This protein exhibits tissue-specific expression in normal adult tissues and is aberrantly expressed in various cancers. The ADCs he describes provide a promising therapeutic option for treating these cancers.
Career Highlights
Throughout his career, Jean Gudas has dedicated himself to advancing cancer treatment methodologies. His work on ADCs represents a critical step in the development of targeted therapies that can improve patient outcomes. His research emphasizes the importance of specificity in drug design.
Collaborations
[This section has been skipped due to space constraints.]
Conclusion
Jean Gudas is a significant figure in the field of antibody drug conjugates, with a focus on innovative cancer therapies. His contributions to the understanding of protein-targeted treatments hold promise for future advancements in oncology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile